None of us knows how we would react if faced with a medical condition that is not treatable at all or offers little hope of recovery. From a state of good health, it is easy to dismiss the possibility of joining a clinical trial, but what if it was your last hope? The subject provokes strong opinions.
Last year has seen Cancer Research UK’s Leeds’ centre running 250 clinical trials with the help of 2,250 volunteers. Using the bench to bedside technique, one example from the centre is the story about one lady, Teri Wadsworth, who found that being involved in the trial of a new chemotherapy drug called Eribulin (Halaven) – derived from a sea-sponge – used in conjunction with other medication, has kept her cancer on hold. Previously there was no treatment with proven survival rates. Now the research team is looking at the possibility of combining Eribulin with other chemotherapy drugs for patients with early stages of breast cancer.
BioKinetic conducts clinical trials in healthy volunteers and patient populations, an essential part of the drug development process. As we all know, patient drug trials are not always successful, however healthy volunteer and patient participation is essential for ongoing new drug developments . The decision to join a clinical trial – or not – may well be conditioned by our experiences of friends or family. For more information, visit www.centerwatch.com . The website publishes every clinical drug trial throughout the world, where it is happening and which medical condition is targets and www.CISCRP.org gives all the information you might need if you are considering taking part in a clinical trial. Please also visit the volunteer section of our website which shows upcoming studies and answers any questions you may have: www.biokineticeurope.com/volunteer_information/
Outsourcing in Clinical Trials for Nordic Companies, 11-12 September, Copenhagen
BioPartnering Future Europe, 13-16 October, Stockholm